연구성과로 돌아가기

2020 연구성과별 연구자 정보 (674 / 2428)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and Safety of a Balanced Salt Solution Versus a 0.9% Saline Infusion for the Prevention of Contrast-Induced Acute Kidney Injury After contrast-Enhanced Computed Tomography Ryu, Dong-Ryeol Ryu, DR 16 Ewha Womans Univ, Dept Internal Med, Mokdong Hosp, Seoul, South Korea kidneyjang@gmail.com;junephro@gmail.com;
Efficacy and Safety of a Balanced Salt Solution Versus a 0.9% Saline Infusion for the Prevention of Contrast-Induced Acute Kidney Injury After contrast-Enhanced Computed Tomography Moon, Sung Jin Moon, SJ 17 Catholic Kwandong Univ, Dept Internal Med, Int St Marys Hosp, Incheon, South Korea kidneyjang@gmail.com;junephro@gmail.com;
Efficacy and Safety of a Balanced Salt Solution Versus a 0.9% Saline Infusion for the Prevention of Contrast-Induced Acute Kidney Injury After contrast-Enhanced Computed Tomography Lee, Jung Eun Lee, JE 18 Samsung Med Ctr, Dept Internal Med, Seoul, South Korea N-5963-2019 Lee, Jun-Young kidneyjang@gmail.com;junephro@gmail.com;
Efficacy and Safety of a Balanced Salt Solution Versus a 0.9% Saline Infusion for the Prevention of Contrast-Induced Acute Kidney Injury After contrast-Enhanced Computed Tomography Huh, Wooseong Huh, W 19 Samsung Med Ctr, Dept Internal Med, Seoul, South Korea kidneyjang@gmail.com;junephro@gmail.com;
Efficacy and Safety of a Balanced Salt Solution Versus a 0.9% Saline Infusion for the Prevention of Contrast-Induced Acute Kidney Injury After contrast-Enhanced Computed Tomography Kang, Ea Wha Kang, EW 20 Ilsan Hosp, Dept Internal Med, Natl Hlth Insurance Serv, Gyeonggi Do, South Korea kidneyjang@gmail.com;junephro@gmail.com;
Efficacy and Safety of a Balanced Salt Solution Versus a 0.9% Saline Infusion for the Prevention of Contrast-Induced Acute Kidney Injury After contrast-Enhanced Computed Tomography Chang, Tae Ik Chang, TI 21 교신저자 Ilsan Hosp, Dept Internal Med, Natl Hlth Insurance Serv, Gyeonggi Do, South Korea kidneyjang@gmail.com;junephro@gmail.com;
Efficacy and Safety of a Balanced Salt Solution Versus a 0.9% Saline Infusion for the Prevention of Contrast-Induced Acute Kidney Injury After contrast-Enhanced Computed Tomography Joo, Kwon Wook Joo, KW 22 교신저자 Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea J-5675-2012 Joo, Kwon kidneyjang@gmail.com;junephro@gmail.com;
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study Kim, Yaerim Kim, Y 1 Keimyung Univ, Dept Internal Med, Div Nephrol, Sch Med, 1035 Dalgubeol Daero, Daegu 42601, South Korea J-5399-2012 Kim, Sang mdjin922@gmail.com;
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study Park, Su-Kil Park, SK 2 Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea mdjin922@gmail.com;
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study Cho, Won Yong Cho, WY 3 Korea Univ, Dept Internal Med, Med Coll, Seoul, South Korea mdjin922@gmail.com;
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study Joo, Kwon Wook Joo, KW 4 Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea J-5675-2012 Joo, Kwon mdjin922@gmail.com;
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study Shin, Sug Kyun Shin, SK 5 Natl Hlth Insurance Corp, Dept Internal Med, Ilsan Hosp, Goyang, Gyeonggi Do, South Korea mdjin922@gmail.com;
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study Kim, Dae Joong Kim, DJ 6 Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea B-2530-2009 Kim, Jae-Hong mdjin922@gmail.com;
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study Kim, Yong-Lim Kim, YL 7 Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea AGK-3172-2022 Kim, Yong-Lim mdjin922@gmail.com;
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study Son, Sung Hyun Son, SH 8 Suyeong Hanseo Hosp, Dept Internal Med, Busan, South Korea mdjin922@gmail.com;
페이지 이동: